Diabetic Ketoacidosis
54
6
7
29
Key Insights
Highlights
Success Rate
81% trial completion
Published Results
11 trials with published results (20%)
Clinical Risk Assessment
Based on trial outcomes
High Risk
Score: 62/100
13.0%
7 terminated out of 54 trials
80.6%
-6.0% vs benchmark
13%
7 trials in Phase 3/4
38%
11 of 29 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.5%
Based on 29 completed trials
Clinical Trials (54)
Biomarkers of Acute Organ Injury in Pediatric Newly Diagnosed Type 1 Diabetes
Impact of Clinical Nursing Guideline on Outcomes of Children With Diabetic Ketoacidosis.
Continuous Glucose Monitoring Using a New Subcutaneous Insulin Protocol for Mild to Moderate Diabetic Ketoacidosis
Relapse Among Diabetic Ketoacidosis Patients Maintained Basal Bolus Insulin Administration in Combination With Continuous Intravenous Insulin Infusion VS Non Maintaining Basal Insulin Patients
A Multi-Disciplinary Technology-Based Care for Diabetic Ketoacidosis in Patients With Type 1 Diabetes
Phase 1 Trial of Arginine Hydrochloride for the Management of Diabetic Ketoacidosis in Type 2 Diabetes
Diabetic Ketoacidosis From New SGLT2i: Can Genomics Estimate Risk
Clinical and Biological Signs of Dapagliflozin Overdose in ICU Patients With Metformin Poisoning
Balanced Multi-Electrolyte Solution Versus Saline Trial for Diabetic KetoAcidosis
Postoperative Euglycemic Ketoacidosis Frequency in Sodium-Glucose Cotransporter-2 Inhibitor Users
Starvation in the Treatment of Diabetic Ketoacidosis
REAMBERIN® 1.5% in Rehydration Therapy of Diabetic Ketoacidosis
Comparison of a Low Dose to a Standard Dose of Insulin in Adult DKA in ICU to Reduce Metabolic Complications
Remote Glucose Monitoring System in Hospitalized Patients With Diabetic Ketoacidosis (DKA)
Serum Ferritin and Prognosis of DKA
Intravenous Fluids in Adults With Diabetic Ketoacidosis in the Emergency Department
Study to Explore the Effect of Dapagliflozin and Stress in Adolescent and Adult Subjects With Type 1 Diabetes (T1D)
Inferior Vena Cava Collapsibility and Distensibility Assessment in Critical Care.
Two Bag System for Diabetic Ketoacidosis
Thiamine As Adjunctive Therapy for Diabetic Ketoacidosis